On July 14, 2026, IM8, David Beckham's longevity drink brand and a Prenetics subsidiary, took $1 billion in non-dilutive financing from General Catalyst's Customer Value Fund. It is not equity and not a normal loan. General Catalyst funds up to 70% of monthly marketing spend and gets repaid a capped share of the revenue those customers generate.
- Non-dilutive means no shares sold, no board seat, no valuation reset. The trade is a slice of future customer revenue, not ownership.
- It is closer to non-recourse leverage than to equity. Prenetics books it as a financial liability with the cost as interest expense.
- Grammarly did the same $1 billion deal in May 2025. The fund has backed nearly 50 companies.
- It only works if your unit economics are genuinely strong. Finance weak cohorts and you have just borrowed against customers who will not pay you back.
Bottom line up front: ignore the celebrity. The interesting thing about IM8's billion dollars is the structure, and it is a structure more consumer brands will be pitched over the next two years. General Catalyst is financing customer acquisition the way a lender finances inventory, and getting paid back only from the customers that spend creates. Used on a business with real, proven economics, it is a genuinely good deal. Used to paper over weak ones, it is expensive leverage with a smile.
I have spent most of my career on the operating side of exactly this decision: how much to spend acquiring customers, and where that money should come from. So I want to strip out the headline and look at the mechanism, because the mechanism is what you will have to judge if a fund like this ever calls you.
What actually
happened.
On July 14, 2026, Prenetics announced $1 billion in growth financing from General Catalyst's Customer Value Fund for its subsidiary IM8, the supplement and longevity-drink brand co-founded by David Beckham and led by CEO Danny Yeung (TechCrunch, July 2026). The number grabs headlines. The word that matters is non-dilutive.
No shares changed hands. No warrants, no convertible notes, no board seat, and no reset of Prenetics' valuation. IM8 sells a subscription vitamin drink, and General Catalyst is financing the cost of acquiring those subscribers, not buying a piece of the company. That is a fundamentally different transaction from the venture raise most people picture when they read "startup gets $1 billion."
It is also not the first of its kind. Grammarly took the same $1 billion from the same fund in May 2025, on more than $700 million in annual revenue, and used it to free up cash for acquisitions rather than to dilute its cap table (TechCrunch, May 2025). By that point the Customer Value Fund had backed nearly 50 companies, including Lemonade and Ro. IM8 is a pattern, not a one-off.
How the money
actually works.
Here is the mechanism, because it is the whole story. General Catalyst finances up to 70% of IM8's marketing spend, cohort by cohort, month by month. In return it collects a capped share of what the company calls reference income, defined as the revenue those financed customers generate multiplied by an assumed gross margin. Once General Catalyst hits its capped return on a given month's cohort, every dollar those customers spend after that belongs to IM8 forever (TechCrunch, July 2026).
The risk sits in an unusual place. There is no fixed repayment schedule, no maturity date, and no covenant. If a financed cohort underperforms, the fund absorbs the shortfall, because its recovery comes solely from those customers, with no recourse to the parent company beyond them. That is genuinely founder-friendly on the downside. But be clear about what it is: Prenetics itself books the facility as a financial liability, with the return recorded as interest expense below operating income. Non-dilutive does not mean free, and it does not mean equity.
Non-dilutive is not the same as risk-free. This is leverage. You are not selling ownership, you are mortgaging a slice of your future customers.
Think of it as the unbundling of a growth round. A traditional late-stage raise funds two very different things at once: the unstructured bets like product and engineering, where the outcome ranges from zero to enormous, and the structured spend on acquiring customers, where a proven brand can predict the return inside a two-to-three-year window. Financing the predictable part separately, and keeping equity for the unpredictable part, is the actual idea here.
| Source | What you give up | Best for |
|---|---|---|
Equity | Ownership, control, upside, forever | Unpredictable bets: product, R&D, new markets |
Traditional debt | Fixed repayment on a fixed schedule, covenants | Predictable cash flows, hard assets, low risk |
CAC financing | A capped slice of the financed customers' revenue | Proven, repeatable acquisition with strong retention |
Why this is
spreading now.
Two forces are pushing this model into the mainstream. The first is the cost of equity. When late-stage venture money was cheap, founders funded everything, including ad spend, by selling shares. Higher interest rates ended the era of free-flowing growth rounds, and repeated dilutive raises got slower and more painful. General Catalyst's own pitch leans hard on the ownership math: most founders own less than 20% of their company by the time it goes public, and some less than 5% (General Catalyst, The Unbundling of Growth Equity). Treat that as advocacy from an interested party, but the underlying frustration is real.
The second force is that subscription and DTC economics are finally legible enough to underwrite. When a brand can show that a given cohort of subscribers reliably pays back its acquisition cost and then some, a financier can treat that spend like an asset instead of a gamble. General Catalyst points to Fivetran as its showcase: the company grew its cash balance by more than $60 million using the fund, versus burning more than $100 million without it, while roughly doubling revenue (General Catalyst). That is the promise: scale proven acquisition without lighting cash or equity on fire.
When it's smart,
and when it's a trap.
Everything about whether this is a gift or a mistake comes down to one question: are your unit economics genuinely strong and genuinely proven? CAC financing does not fix a weak business. It amplifies whatever business you already have. Point it at cohorts that pay back fast and retain well, and you compound. Point it at cohorts propped up by an optimistic lifetime-value model, and you have borrowed against customers who will churn before they earn out.
IM8's own case is the tell. The company says every dollar it has ever spent acquiring customers has already returned $1.44 in gross profit, and that the figure rises each month because these are subscribers (Prenetics, July 2026). Those are company-reported, unaudited figures, so weigh them accordingly. But if they are close to true, IM8 is exactly the profile this financing is built for: a proven, repeatable acquisition engine that just needs more fuel. The classic benchmark still applies here, an LTV to CAC ratio comfortably above 3 to 1, a rule of thumb popularized by David Skok more than a decade ago and still the right instinct.
Your retention is weaker than your model. The structure is only as good as your cohort retention. Modest monthly churn compounds fast, and DTC subscriptions routinely lose a chunk of buyers in the first 90 days. If real cohorts decay faster than the pitch deck assumed, the financed spend never earns out.
You misread the cost of capital. A small repayment multiple over a short cohort life can translate to an effective annual rate well into the double digits. A capped revenue share is not a low interest rate just because it is not labeled one.
You treat it as a reason to spend more. When someone else fronts 70% of the ad bill, the temptation is to scale acquisition past the point where it is actually profitable. The financing does not make bad spend good.
The honest framing that most coverage skips: this is leverage. Founder-friendly, non-recourse, cohort-matched leverage, but leverage. The critics who call it debt in disguise are not wrong about the structure, even if they undersell how much better the terms are than a bank loan. If your economics are real, it is a smart way to grow without giving up ownership. If they are not, you have added risk to a business that could not afford it.
Before you finance acquisition, know your ceiling. The Max Allowable CAC calculator shows the most you can spend per customer and still make money.
What it signals
for your brand.
Most brands reading this are not raising a billion dollars. But the model scales down, and a wave of financiers already offers smaller-ticket versions of the same idea, from Wayflyer and Clearco to Capchase and Shopify Capital. The lesson is not "go get CAC financing." It is that clean, provable unit economics are becoming a fundable asset in their own right, and the brands that can demonstrate them will have access to cheaper growth capital than the ones that cannot.
So the takeaway is the same one I push in every finance conversation. The work is not chasing the clever funding structure. The work is earning the economics that make the structure available: strong contribution margin, fast payback, and retention you can actually prove. Get those right and options like this open up. Get them wrong and no financing fixes it, it just makes the hole more expensive. That starts with the margin math in the three-layer contribution margin read and an honest look at the LTV math brands get wrong. For the wider view of who is funding consumer brands right now, see the funding rounds tracker.
Questions I keep
getting asked.
It is a non-dilutive financing vehicle that pre-funds a company's sales and marketing spend and gets repaid only from the revenue those specific customer cohorts generate, capped at a fixed return. No equity, no board seat, no valuation reset. After the cap, all further customer value stays with the company.
IM8, a Prenetics subsidiary, secured a $1 billion Customer Value Fund facility on July 14, 2026. It is non-dilutive: no shares, warrants, or convertibles are issued. General Catalyst finances up to 70% of monthly marketing spend and recovers a capped share of revenue from the financed cohorts, with no recourse beyond them.
Functionally it is closer to non-recourse, cohort-matched leverage than to equity. Prenetics books the facility as a financial liability with the return recorded as interest expense. Unlike a bank loan, there is no fixed schedule, maturity, or covenant, and repayment tracks only the financed customers' revenue.
Companies with proven, predictable unit economics: strong and consistent LTV to CAC, fast payback, and durable retention, usually on a subscription model. General Catalyst targets mature or public companies spending roughly $2M to $20M a month on marketing. It is dangerous for businesses with high churn or inflated lifetime-value assumptions.
Grammarly took $1 billion from the fund in May 2025. Other named participants include Lemonade, Ro, and Fivetran, and the fund has backed nearly 50 companies. Fivetran cited a cash-balance swing of roughly $160 million versus scaling without it, per General Catalyst.
Higher interest rates ended cheap late-stage equity, and founders resist further dilution after years of ownership erosion. Financing customer acquisition separately preserves equity for product and R&D. The idea is to treat proven ad spend like an asset to be financed rather than a cost funded by selling shares.
Watch this space. The names will get less famous and the checks will get smaller, but the model is coming for the consumer-brand middle. The brands that win access are the ones that did the boring work of proving their economics first. Start there, with contribution margin and the Max Allowable CAC math.
Thinking about borrowing against your customers?
I help founders pressure-test the unit economics before they finance acquisition, so the growth capital compounds instead of compounding a problem. Bring your cohorts and your CAC, I will tell you whether the math actually holds.
Start a conversation More about Taylor →